Cargando…
B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools
B cell hyperactivity is a hallmark of the complex autoimmune disease systemic lupus erythematosus (SLE), which has justified drug development focusing on B cell altering agents during the last decades, as well as the off-label use of B cell targeting biologics. About a decade ago, the anti-B cell ac...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468481/ https://www.ncbi.nlm.nih.gov/pubmed/36111105 http://dx.doi.org/10.3389/fmed.2022.952304 |